chrisvoncsefalvay/vaers-outcomes huggingface dataset:
flu; Initial information received on 01-Oct-2021 regarding an unsolicited valid Social Media serious case from a consumer/non-hcp professional. This case involves an unknown age male patient who had flu (influenza) and died, after receiving INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  The patient's past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date not reported) via unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE. This event was leading to death.  The patient did not experience any additional symptoms/events.  It was unknown if there were laboratory data/results available  It was not reported if the patient received a corrective treatment.  At time of reporting, the outcome was fatal for the reported event.  It was unknown if an autopsy was done. The cause of death was reported as influenza.  Information on the batch number to be requested.; Sender's Comments: This poorly documented social media case concerns a  male patient (age unknown) who had influenza and died, after vaccination with  INFLUENZA VACCINE (produced by unknown manufacturer). The time to onset is unknown. It was unknown if an autopsy was done. Further information regarding patient's past medical condition, previous vaccination tolerance and other laboratory investigations excluding alternative etiologies for the reported event are needed to fully assess this case. Based upon the reported information, the role of a suspect vaccine cannot be assessed.; Reported Cause(s) of Death: flu
Rapid COVID test was positive/Next day long test came back negative and was quickly moved out of the COVID-19 unit; Hemoglobin Anemia; difficulty breathing; fast heartbeat; dizziness; weakness; tiredness; over all feeling of unwell.; This is a spontaneous report from a contactable consumer (patient). An 82-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 19Mar2021 10:00 (Lot Number: EN6198) as SINGLE DOSE for COVID-19 immunization. Medical history included lower left lung lobectomy in Mar2019 and cancer in May-Jul2019 treated with chemotherapy 4x. The patient previously had first dose of BNT162B2 in the left arm on 26Feb2021 10:00, lot number: EN5318 for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 20Mar2021 06:00, 1 day later had side effects of tiredness and over all feeling of unwell. On 22Mar2021, 3 days later, the patient had additional side effects of difficulty breathing, fast heartbeat,dizziness and weakness. On the 6th day, the patient went to ER 26Mar2021, the patient was admitted to the hospital. Rapid COVID-19 test was positive and sent to COVID-19 unit. Next day long test came back negative and was quickly moved out of the COVID-19 unit. The patient was diagnosed with hemoglobin anemia. Over all, hemoglobin dropped from normal base line of 14 to 6.1. The patient was given 2 units of blood, was given a shot of prednisone and then put on 60 mg of prednisone daily. Release from hospital after 6 days with hemoglobin of 9.9. Still being followed by doctor and follow up blood work. Continuing 60mg of prednisone daily until hemoglobin reaches normal range. If prednisone does not work, next step is an infusion of Rituxan. The patient underwent lab tests and procedures which included haemoglobin: 9.9 on unspecified date, haemoglobin: dropped from normal base line of 14 to 6.1 on 27Mar2021, long test: negative   on 27Mar2021 and Nasal swab/Rapid test: positive on 26Mar2021. All events were reported as life threatening. The outcome of the events was recovered with lasting effect
Received the vaccine on Saturday. Woke up on Sunday with what felt like a very bad hangover - muscle aches, no energy, no appetite. Alternating freezing and hot sweats. Did not have a thermometer to check for a fever.  By Wednesday I was still not feeling well. All the same symptoms. Was in bed all day. I heard most people had a 24-48 hour reaction. This was longer. I called the Dr. He advised alternative tylenol and advil to get fever under control. If this wasn't cleared up by that Friday he would have me come in for tests.  Friday morning was the first morning I was "fever" symptom free. It took until about Sunday for my energy to return. So this was about an 8 day reaction.   Not sure if this is related, but beginning in August I started having problems with my asthma - chest pains, very low energy, steroid inhaler was not helping. I have since been diagnosed with "severe asthma". I'm not sure if this is related to the vaccine. But I have an aunt who never had asthma problems in her life, now needs an inhaler to go running, and a cousin who has since developed excema.  Are these all covid related? Not sure, hopefully this data helps you.
Very loud tinnitus and ears feel stuffed up.  It is affecting my sleep and day time functioning and affecting my hearing.
The patient received a total of 4 doses of GARDASIL 9; No adverse information provided; This spontaneous report has been received from a registered nurse, concerning a patient of unknown age, gender and ethnicity.  The patient's concurrent conditions, pertinent medical history, concomitant medications and drug reactions or allergies were not reported.   On an unspecified date, the patient was administered a dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis. It was reported that the patient received a total of 4 doses of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (inappropriate schedule of product administration). No adverse symptoms reported.
pt recv vax & devel anaphylaxis, cough, hypotension & urticaria;
5 days p/vax pt had a grand mal sz following a fever of 102 ax;dx fever, febrile sz;pt fuzzy last evening;pt has diffuse vesicular eruption on trunk & extremities;spinal protein 119;
By that evening, I experienced severe body aches, chills and fever that lasted approximately 3 days.  Shortly afterward, began to have what I thought was a clogged ear.  Thought I was possibly starting with a cold or sinus.  By the following week, ear worsened, and  I felt pain/pressure on the left side of my face, around eye and ear and neck. By Thanksgiving I noticed my hearing was declining, and it felt very, very uncomfortable.  Again, I thought it was possibly a severe sinus infection.   The clogged feeling/noise / etc. increased - Dr. prescribed steroids and antibiotics - despite lack of any nasal discharge.  Advised to see an ENT.  Audiology report showed hearing loss in left ear, MRI was normal, loss pattern consistent  with damage to the nerve. I still have this very uncomfortable feeling on the left side of my neck, along with the pressure (hard to describe) feeling in my ear.  Also experiencing periods of hoarseness
Felt fine during the waiting period after receiving the vaccine.  As I was walking through the parking lot started feeling very light headed.  Went home and rested, took Tyenol but the dizziness never went away.  When I laid down in bed it felt like the room was spinning.  Woke up today and still feel dizzy and light headed.  The only other side affect is a really dry mouth and throat.
Tender; sore to the touch or clothing; blistered rash the size of a quarter; Got pressure in the middle of my chest and both breasts; Tiredness; weakness; This is a spontaneous report from a contactable consumer (Patient). A 74-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 05Feb2021 12:00 (Batch/Lot Number: EN6201) as single dose for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included lorazepam 1mg, metoprolol succinate 25 mg (TOPROL XL) taken for an unspecified indication, start and stop date were not reported. On 05Feb2021, the patient experienced got pressure in the middle of my chest and both breasts, tiredness and weakness, On 07Feb2021, blistered rash the size of a quarter, On an unspecified date, tender and sore to the touch or clothing. Day 1 I got pressure in the middle of my chest and both breasts. Tiredness and weakness. Day 2 it slowly eased. Day 3 I got a red blistered rash the size of a quarter directly above my right nipple. It has been 13 days and the rash has gotten smaller to the size of a dime with blisters remaining. The sight is tender and sore to the touch or clothing. The action taken in response to the event for BNT162B2 was not applicable. The outcome of events for tender and sore to the touch or clothing was unknown, for blistered rash the size of a quarter it was recovering while for the rest of the it was not recovered.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (lot number was reported as J000447, expiry date 11-APR-2014, route and dose were not reported). On an unknown date, the patient experienced swelling at the injection site after receiving ZOSTAVAX. The outcome of swelling at the injection site was unknown. This is one of the several reports received from the same reporter. Additional information is not expected.
a little arm pain; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 27-JUL-2023, the patient received Shingles vaccine. On 27-JUL-2023, less than a day after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: a little arm pain). The outcome of the pain in arm was not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm to be related to Shingles vaccine.   Additional Information: GSK receipt date: 27-JUL-2023 The case was received from the patient interactive digital media. The patient thankful, as on the day of reporting he/she had an appointment at the clinic and asked for the vaccine, and could you believed that they gave it to him/her now, just a little pain in my arm. The patient hoped it helped, she did not had shingles, just for prevention. The patient saw a lot of the comments of those who went through it and it scared him/her. The patient hoped everything would be fine. The patient thanked for your comments and blessings. The follow-up could not be possible as no contact details were available.
This spontaneous report as received from a nurse refers to a 19 year old patient of unknown gender. The patient's pertinent medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient inadvertently received a pediatric dose of VAQTA injection, intramuscularly 25/0.5 ml (lot # N020689, expiration date 22-OCT-2018) for prophylaxis, as second dose in VAQTA immunization series. No adverse effects reported.
Dull pain and slight swelling at the injection site. Red, itchy, circular rash around the injection site approximately 13 days post injection.
Pain in upper abdomen, nausea, feeling unwell, fatigued, chills, headache. Layer developed dissented stomach and fluid retention in legs and feet. Hospitalized 3/24/21. Acute liver failure, and acute renal failure.  Possible  Rhabdomyolysis.
suspected vaccination failure; shingles; got sick; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose and Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and sickness. On an unknown date, the outcome of the vaccination failure, shingles and sickness were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and sickness to be related to Shingrix and Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient had completed Shingrix protocol. The patient did not understand how a vaccine like this was ever approved by the Food and drug administration (FDA). The patient would expect therapies for cancer, human immunodeficiency virus (HIV) or other lifethreatening illnesses to have the effects that this vaccine. The patient think would have rather gotten the shingles. On top of that, the clinicals the patient researched indicate that it only has a full efficacy for 4 years. The patient would make my experience known to the FDA. Unfortunately they did not respond to patient calls. If they have any compassion toward the users this therapy targets, they will put their scientists to work on developing a decent vaccine that is not intended to make one sick in order to avoid getting sick with shingles. This case was considered as suspected vaccination failure as the details regarding vaccination schedule and time to onset for the event was unknown at the time of reporting.
Itchy burny skin rash started in right armpit and lower back, then migrated sequentually to left armpit, the sides of both breasts, the back of the right shoulder, the left thigh, and finally to the abdomen. The rash starts as fine red spots that later become inflamed and join to form large irregular patches that could be a 2 or 3 inches in diameter. Televisited primary care physician who prescribed Zyrtec twice a day and Caladryl topical lotion and referred me to a dermatologist who prescribed 0.05% Clobetasol Propionate Ointment and Benadryl as needed. The rash persisted and became worse after the 2nd shot 21 days later, but was fading slightly and was less itchy and burny just before the 2nd shot.  Will report 2nd shot events separately later.
Information has been received from a physician concerning a female who on 14-AUG-2007 was vaccinated with a first dose of GARDASIL (Lot# reported as 22U).  Within the same day the patient developed a hive on top of her hand where she received the shot.  It was unknown whether medical attention was sought.  The patient had not received subsequent doses due to the allergic reaction she had.  The patient's outcome was not reported.  Additional information has been requested.
raised, itchy erythema at site of vaccine.  The itchiness became  noticeable approximately 12 hours after receiving the vaccine and upon waking that morning the patch of erythema was observed.  Approximately 16 hours after vaccine I applied diphenhydramine OTC gel to the  inflamed, itchy  skin.  The patch continued to expand and raise during that day.  It began to extend around my arm.  At approximately 30 hours after the vaccine I took 25 mg of dipehnhydramine tablet.  I continued to apply the diphenhydramine OTC gel to the raised welt approximately every 4 hours throughout the day following the vaccine.   That evening I took another 25 mg of diphenhydramine at approximately 8pm.  The red welt area continued to expand for the next day beyond the margin I had marked with a pen the first night following the vaccine.  The swelled, red area reached approximately 3cm x 6 cm.  I continued to treat with the diphenhydramine gel and that eveing (2nd day after vaccine) I took diphenhydramine 50 mg.  The following morning the erythema remained but the height of the swelling had been to reduce and it was somewhat less itchy.  The condition continued to improve but at two weeks post vaccine there was still a light red patch on my arm.  At three weeks there is a slight outline of the affected area still visible. This area has a darker color than the rest of my arm, somewhat like a bruise.
Received vaccine 9/22/17. Reported upper respiratory tract infection "1-2 days prior to the onset of his symptoms", no additional description offered. Developed bilateral lower extremity tingling and some weakness 9/25/17 morning, progressing to hand and shoulder. On 9/26/17 reported to PCP muscles of chest abdomen somewhat weaker. Admitted 9/26/17 with diagnosis Guillain-Barre syndrome following vaccination and ascending paralysis. Transferred to ICU 9/27/17 to closely monitor respiratory status and negative inspiratory force. Completed 5 day course IVIG, improved, transferred to intermediate care 9/30/17. Planned transfer to Inpatient Rehab Unit 10/2/17.
Headache; Body aches; low grade fever; This is a spontaneous report from a contactable consumer. A 51-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 5318), via unspecified route of administration in the right arm on 17Mar2021 at 02:00 PM (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history was not included. The patient was not having allergies to medications, food, or other products. The patients concomitant medications include Zyrtec (MANUFACTURE UNKNOWN) from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Previously the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 5318), via unspecified route of administration in the right arm on 26Feb2021 at 02:00 PM as a single dose for COVID-19 immunisation.  On 18Mar2021 at 02:00 PM, the patient experienced Headache, body aches, low grade fever approx. 24 hours after injection that lasted approx. 24 hours. The Clinical outcomes of Headache, body aches and low-grade fever were recovered.   No follow-up attempts are needed. No further information is expected.
I had a mild headache and achiness starting around 5:30 accompanying severe chills that later developed into a fever of 103.  I took two Ibuprofen around 11:00 pm but the fever did not go down for several more hours.   I also had a rapid heart beat while I had the fever.  I was OK in the morning but still tired and low energy.
Pt developed hives all over his body 10 hours after receiving the flu vaccine.  Hives associated with itching; relieved with over the counter Benadryl but receives when wears off.  Generalized mild erythematous rash; few are urticarial.  Pt given allegra 180mg every day for 10 days.
Narrative: 93 year old male admitted on September 18 2022 with hypoxia (89%) and back pain. He had received Moderna vaccine x 2 on February 12 2021, March 12 2021. He was treated with dexamethasone 6 mg daily x 2 days. Remdesivir deferred due to eGFR. Back pain significantly imprved and he was discharged on 9/20.
Patient presented to the ED and was subsequently hospitalized within 6 weeks of receiving COVID vaccination. Diagnosis was Stevens-Johnson disease.
First series was given with a flu shot, SEQIRUS, lot yf36905. Following day had flu symptoms of achy skin and shivers. This lasted one day. The following day felt excellent. Second series, the following day I felt tired, cold (shivers). This lasted 3 days. On 2/4/2019 I noticed a red band below the shot area on my arm. It was hot and sore and itchy. I felt shooting pains in my forearm-top between the wrist and elbow.
This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient concurrent conditions, medical history, drug reactions and allergies were not reported. Concomitant therapies included sterile diluent. On 05-APR-2018, the patient was vaccinated with VARIVAX (dose, units and frequency not reported) (lot# N030407 and expiration date: 30-OCT-2019) via intramuscular route. No adverse effects reported. No product complaint was involved. Lot number [N030407] has been verified to be a valid lot number for VARIVAX.
On 10/12/2022 Covid Bivalent Pfizer was given IM for a first time dose.
Extreme pain/ weakness in left elbow and arm. No treatment yet. Going to facility next week.
This was patient's 2nd flu shot in the 2021-2022 season. First shot given 9/30/21. Patient reports no adverse events. He did not remember getting the first shot.
Several hours after both the first and second vaccines, I started shivering and felt chills. Then symptoms included 102 + fever, muscle aches, bone and tooth aches, sick feeling and achy stomach, pounding headache, muscle weakness, feeling "foggy", similar to a hangover type of feeling. Most symptoms lasted for about a day and a half. Headaches, fogginess, and weakness lasted for an additional 2 days.
The initial case was missing the following minimum criteria: unspecified adverse event. Upon receipt of follow-up information on 04Oct2018, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable certified medical assistant calling on behalf of a physician and of the patient. A 69-year-old female patient received PREVNAR 13 (lot W11306) on 28Sep2018, at 0.5 ml single dose, intramuscular, in arm, for pneumonia prevention. Medical history and concomitant medications were not reported. On 28Sep2018 the patient experienced redness from shoulder to right above the elbow and shoulder warm to touch. The patient iced her arm over the weekend but the redness did not go away. The patient had no fever and everything else was normal. The events had not yet resolved at the time of report. The reporter considered there was a reasonable possibility that redness was related to PREVNAR 13. Causality for the event shoulder being warm to touch was not provided.
small bruise @ inj site;c/o onset of tingling in arm day of immun;pt in clinic today no complaints advised to f/u w/MD if arm tingles or burns;
This is a spontaneous report from a contactable consumer (patient). A female patient, of an unspecified age, received the 1st dose of BNT162B2 (Comirnaty, batch/lot# not reported), via an unspecified route of administration, on Mar 24, 2021, single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. Prior vaccination, patient was exposed to COVID. On Mar 24, 2021, patient experienced blurring of vision, fever and headache. Her second dose scheduled on Apr 14, 2021. The outcome of the events: unknown. No follow-up attempts possible. Information about lot/batch number cannot be obtained. No further information expected.
2 1/2 cm x 2 1/2 cm erythema reaction (L) posterior upper arm. Warm to touch.
Covid19 breakthrough.  1st Vaccine on 01/11/2021.  95y/o with PMH of dementia presents to ED with c/o lethargy, loss of appetite, low grade temps and slight rhinorrhea.  CXR-patchy vague Bilat opacities, room air sat 98%.  Started on IV ABX, oral steroids and Remdesivir.